NeuroproteXeon

Major Drugs - Orchard Park, NY, US

NeuroproteXeon Details

NeuroproteXeon is a late clinical-stage pharmaceutical company developing the proprietary use of xenon gas, delivered via a patented inhalation device, to protect against brain cell death following acute neurologic injury. NP is currently preparing for a Phase III Clinical Trial in Out of Hospital Cardiac Arrest (OHCA).

NeuroproteXeon logo, NeuroproteXeon contact details
Employees: 20 - 49
HQ: 716-332-7200
Location: Orchard Park, NY, US
Revenue: 2.5 - 5 Million
Innovative neuroprotective agent and therapy development Improvement of mortality rates and neurologic function in patients experiencing acute brain injury
NeuroproteXeon Technologies
Email Providers

Outlook

CMS

WordPress.org

Fonts

Google Font API

Other

Microsoft Office 365

Hosting

GoDaddy Hosting

Analytics and Tracking

Google Analytics

View All Technologies Used At NeuroproteXeon

Contacting NeuroproteXeon: Connect with Executives and Employees

Get in Touch with NeuroproteXeon Executives and Employees

Connecting with NeuroproteXeon's Executives and Workforce

Accessing Contact Information for NeuroproteXeon Executives

Connecting with NeuroproteXeon: Reach Out to Their Team

Discover How to Contact NeuroproteXeon Executives and Staff

Looking to connect with NeuroproteXeon executives or employees?

Seeking to Get in Touch with NeuroproteXeon Executives or Staff?

Want to Reach Out to NeuroproteXeon Executives or Team Members?

In Search of Contact Details for NeuroproteXeon Professionals?

Connecting with NeuroproteXeon: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z